Pseudobulbar Affect in Parkinsonian Disorders: A Review

다국어 초록 (Multilingual Abstract)

Pseudobulbar affect (PBA) is a neurological symptom of inappropriate and uncontrollable laughter or crying that occurs secondary to a variety of neurological conditions, including parkinsonian disorders. PBA is a socially and emotionally debilitating symptom that has been estimated to affect 3.6% to 42.5% of the population with Parkinson’s disease. While indexing measures and treatment options for PBA have been extensively studied in neurological conditions such as amyotrophic lateral sclerosis and multiple sclerosis, there has been considerably less attention given in the literature to PBA in parkinsonian disorders. The purpose of this review is to discuss the pathophysiology of PBA, its prevalence and impact on quality of life in parkinsonian disorders, and the treatment options currently available. Areas requiring further study, including the development of standardized, cross-culturally validated methods of symptom assessment, and evidence-based studies exploring the efficacy of current treatment options in parkinsonian disorders, are also highlighted.

참고문헌 (Reference)

1 Smith RA, "Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients" 10 : 679-685, 2004

2 Okun MS, "Treatment of pseudobulbar laughter after gamma knife thalamotomy" 17 : 622-624, 2002

3 Brooks BR, "Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine:a randomized trial" 63 : 1364-1370, 2004

4 Arciniegas DB, "The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting" 10 : 1-14, 2005

5 Arif H, "Stimulus-induced pathologic laughter due to basilar artery dissection" 64 : 2154-2155, 2005

6 Panitch HS, "Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis" 59 : 780-787, 2006

7 Chattha PK, "Pseudobulbar laughter as a levodopa off phenomenon exacerbated by subthalamic deep brain stimulation" 2 : 13-, 2015

8 Okun MS, "Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus" 75 : 921-923, 2004

9 Miller A, "Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments" 11 : 1077-1088, 2011

10 Strowd RE, "Pseudobulbar affect: prevalence and quality of life impact in movement disorders" 257 : 1382-1387, 2010

11 Colamonico J, "Pseudobulbar affect: burden of illness in the USA" 29 : 775-798, 2012

12 Work SS, "Pseudobulbar affect: an under-recognized and under-treated neurological disorder" 28 : 586-601, 2011

13 Patel N, "Pseudobulbar affect correlates with mood symptoms in parkinsonian disorders but not amyotrophic lateral sclerosis" 30 : 214-219, 2018

14 Tei H, "Pontine infarction due to basilar artery stenosis presenting as pathological laughter" 39 : 190-191, 1997

15 Pope LE, "Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers" 44 : 1132-1142, 2004

16 Oh K, "Pathological laughter as an unusual manifestation of acute stroke" 59 : 83-84, 2008

17 Parvizi J, "Pathological laughter and crying: a link to the cerebellum" 124 (124): 1708-1719, 2001

18 Parvizi J, "Pathological laughter and crying in patients with multiple system atrophy-cerebellar type" 22 : 798-803, 2007

19 Robinson RG, "Pathological laughing and crying following stroke: validation of a measurement scale and a double-blind treatment study" 150 : 286-293, 1993

20 Wilson SA, "Pathological laughing and crying" 16 : 39-40, 1923

21 Low HL, "Pathological crying caused by high-frequency stimulation in the region of the caudal internal capsule" 65 : 264-266, 2008

22 Kim JS, "Pathologic laughter after unilateral stroke" 148 : 121-125, 1997

23 Andersen G, "Pathoanatomic correlation between poststroke pathological crying and damage to brain areas involved in serotonergic neurotransmission" 25 : 1050-1052, 1994

24 Brooks BR, "PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions" 8 : e72232-, 2013

25 Hammond FM, "PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury" 16 : 89-, 2016

26 Smeding HM, "Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study" 66 : 1830-1836, 2006

27 Parvizi J, "Neuroanatomy of pathological laughing and crying: a report of the American Neuropsychiatric Association Committee on Research" 21 : 75-87, 2009

28 Kim SW, "Mirtazapine treatment for pathological laughing and crying after stroke" 28 : 249-251, 2005

29 Thakore NJ, "Laughter, crying and sadness in ALS" 88 : 825-831, 2017

30 Phuong L, "Involuntary emotional expression disorder (IEED) in Parkinson’s disease" 15 : 511-515, 2009

31 Demler TL, "Introduction to pseudobulbar affect: setting the stage for recognition and familiarity with this challenging disorder" 23 : S339-S344, 2017

32 Siddiqui MS, "Inappropriate crying and laughing in parkinson disease and movement disorders" 10 : 234-240, 2009

33 Floeter MK, "Impaired corticopontocerebellar tracts underlie pseudobulbar affect in motor neuron disorders" 83 : 620-627, 2014

34 Petracca GM, "Frequency and correlates of involuntary emotional expression disorder in Parkinson’s disease" 21 : 406-412, 2009

35 Brown KW, "Fluoxetine as a treatment for poststroke emotionalism" 98 : 455-458, 1998

36 Parvizi J, "Exaggerated crying and tremor with a cerebellar cyst" 19 : 187-190, 2007

37 Schoedel KA, "Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect" 10 : 1161-1174, 2014

38 Ferentinos P, "Duloxetine for pathological laughing and crying" 12 : 1429-1430, 2009

39 Yang LP, "Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect" 75 : 83-90, 2015

40 Pioro EP, "Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect" 68 : 693-702, 2010

41 Cummings JL, "Defining and diagnosing involuntary emotional expression disorder" 11 : 1-7, 2006

42 Famularo G, "Cerebellar tumour presenting with pathological laughter and gelastic syncope" 14 : 940-943, 2007

43 Olney NT, "Behaviour, physiology and experience of pathological laughing and crying in amyotrophic lateral sclerosis" 134 (134): 3458-3469, 2011

44 Pattee GL, "An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions" 30 : 2255-2265, 2014

45 Moore SR, "A self report measure of affective lability" 63 : 89-93, 1997